XML 44 R33.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of Preferred Stock Dividend Declaration and Payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2021 through September 30, 2021:

Declaration Date Record DatePayment DateDividend Per Share
August 26, 2021September 8, 2021September 30, 2021$0.46875
May 24, 2021June 7, 2021June 30, 2021$0.46875
February 19, 2021March 5, 2021March 31, 2021$0.46875
The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2021 through September 30, 2021:

Declaration Date Record DatePayment DateDividend Per Share
August 26, 2021September 8, 2021September 30, 2021$0.40625
May 24, 2021June 7, 2021June 30, 2021$0.40625
February 19, 2021March 5, 2021March 31, 2021$0.40625
Schedule of Common Stock Dividend Declaration and Payment
The following table presents cash dividends declared by the Company on its common stock from January 1, 2021 through September 30, 2021:

Declaration Date
Record DatePayment DateDividend Per Share 
September 15, 2021September 30, 2021October 29, 2021$0.100(1)
June 15, 2021June 30, 2021July 30, 2021$0.100
March 12, 2021March 31, 2021April 30, 2021$0.075
(1) At September 30, 2021, we had accrued dividends and dividend equivalents payable of $44.2 million related to the common stock dividend declared on June 15, 2021.
Schedule of changes in balances of each component of the entity's AOCI
The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2021:
Three Months Ended
September 30, 2021		Nine Months Ended
September 30, 2021
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss)
on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (3)
Total 
AOCI		Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss)
on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (3)
Total 
AOCI
Balance at beginning of period$66,163 $— $(1,588)$64,575 $79,607 $— $(2,314)$77,293 
OCI before reclassifications(8,029)— 209 (7,820)(21,473)— 935 (20,538)
Amounts reclassified from AOCI (1)
— — — — — — — — 
Net OCI during the period (2)
(8,029)— 209 (7,820)(21,473)— 935 (20,538)
Balance at end of period$58,134 $— $(1,379)$56,755 $58,134 $— $(1,379)$56,755 

(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
(3) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
 

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2020:
Three Months Ended
September 30, 2020		Nine Months Ended
September 30, 2020
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities		Net Gain/(Loss) on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (3)
Total
AOCI		Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss) on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (3)
Total
AOCI
Balance at beginning of period$52,889 $(7,176)$— $45,713 $392,722 $(22,675)$— $370,047 
OCI before reclassifications15,082 — (22,652)(7,570)408,585 (50,127)(22,652)335,806 
Amounts reclassified from AOCI (1)
(60)7,176 — 7,116 (733,396)72,802 — (660,594)
Net OCI during the period (2)
15,022 7,176 (22,652)(454)(324,811)22,675 (22,652)(324,788)
Balance at end of period$67,911 $— $(22,652)$45,259 $67,911 $— $(22,652)$45,259 

(1)  See separate table below for details about these reclassifications.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
(3) Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
Information about the significant amounts reclassified out of the entity's AOCI
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2021:
Three Months Ended
September 30, 2021		Nine Months Ended
September 30, 2021
Details about AOCI ComponentsAmounts Reclassified from AOCIAffected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities
$— $— Net realized gain/(loss) on sales of securities and residential whole loans
Impairment recognized in earnings
— — 
Other, net
Total AFS Securities$— $— 
Total reclassifications for period$— $— 
 
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2020:
Three Months Ended
September 30, 2020		Nine Months Ended
September 30, 2020
Details about AOCI ComponentsAmounts Reclassified from AOCIAffected Line Item in the Statement
Where Net Income is Presented
(In Thousands)
AFS Securities:
Realized gain on sale of securities$(60)$(389,127)Net realized gain/(loss) on sales of securities and residential whole loans
Impairment recognized in earnings— (344,269)Other, net
Total AFS Securities$(60)$(733,396)
Swaps designated as cash flow hedges:
Amortization of de-designated hedging instruments7,176 72,802 Other, net
Total Swaps designated as cash flow hedges7,176 72,802 
Total reclassifications for period$7,116 $(660,594)